Overview
In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8.
Secondary endpoints:
- An artificial intelligence model's precision in predicting a new flare within 2 and 3 years
- An artificial intelligence model's precision to rule out patients who will not experience a new flare within 1, 2 and 3 year
Eligibility
Inclusion criteria:
- Signed informed consent
- Diagnosis of UC for at least 1 year
- Relapse due to UC.
- First endoscopic and histological evaluation of the flare Exclusion criteria
- Well-founded doubt that the flare is due to other than the patients UC